1
|
Zou S, Cao L, Zhang X, Chen C, Tada M, Muratsugu S, Tian R, Sun H, Li A, Han X, Liao X, Huang J, Masri AR. 'Tearing Effect' of Alloy-Support Interaction for Alloy Redispersion in NiRu/TiO 2 Hydrogenation Catalysts. Angew Chem Int Ed Engl 2025; 64:e202425066. [PMID: 39918915 DOI: 10.1002/anie.202425066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Revised: 02/06/2025] [Accepted: 02/07/2025] [Indexed: 02/09/2025]
Abstract
Supported alloy catalysts have been extensively applied to many significant industrial chemical processes due to the abundant active sites with distinguishable geometry and electron states. However, a detailed in situ investigation of the interaction between support and alloy nanoparticles is still lacking. Here, a subversive 'tearing effect' on the interface of TiO2-supported NiRu alloy nanoparticles is in situ discovered by environmental transmission electron microscopy (ETEM) with a dramatic redispersion process of alloy nanoparticles from ~25 nm to 2-3 nm under the repeated hydrogen reduction. Dual-driven by the distinct alloy-support interaction involving the restructuring of alloy nanoparticles and growth of TiOx overlayer, larger NiRu alloy nanoparticles spontaneously disintegrate into atoms migrating on support. Atoms are finally captured by the defects generated on TiO2 during the repeat reduction, which also confines the further growth of the newly alloy nanoparticles. Owing to this specific alloy-support interaction, smaller alloy nanoparticles on TiO2 support are much more stable than the bigger ones, which holds promise for industrial applications as durable catalysts. This novel metal-support interaction with the 'tearing effect' revealed on supported alloy catalysts provides new knowledge on the structure-performance relationships in all the alloy catalysts for hydrogenation reactions.
Collapse
Affiliation(s)
- Sibei Zou
- Department: School of Aerospace, Mechanical and Mechatronic Engineering, Institution, The University of Sydney, J07 The University of Sydney, New South Wales, 2006, Australia
| | - Liwei Cao
- Department: Beijing Key Laboratory of Microstructure and Property of Advanced Materials, Institution, Beijing University of Technology, Faculty of Materials and Manufacturing, Beijing, 100124, China
| | - Xingmo Zhang
- Department: School of Chemical and Biomolecular Engineering, Institution: The University of Sydney, J01 The University of Sydney, New South Wales, 2006, Australia
| | - Chaoqi Chen
- Department: Department of Chemistry, Institution: Nagoya University, Graduate School of Science/Research Centre for Materials Science, Nagoya, 464-8602, Japan
| | - Mizuki Tada
- Department: Department of Chemistry, Institution: Nagoya University, Graduate School of Science/Research Centre for Materials Science, Nagoya, 464-8602, Japan
| | - Satoshi Muratsugu
- Department: Department of Chemistry, Institution: Nagoya University, Graduate School of Science/Research Centre for Materials Science, Nagoya, 464-8602, Japan
| | - Rongying Tian
- Department: School of Aerospace, Mechanical and Mechatronic Engineering, Institution, The University of Sydney, J07 The University of Sydney, New South Wales, 2006, Australia
| | - Haoyue Sun
- Department: School of Chemical and Biomolecular Engineering, Institution: The University of Sydney, J01 The University of Sydney, New South Wales, 2006, Australia
| | - Ang Li
- Department: Beijing Key Laboratory of Microstructure and Property of Advanced Materials, Institution, Beijing University of Technology, Faculty of Materials and Manufacturing, Beijing, 100124, China
| | - Xiaodong Han
- Department: Beijing Key Laboratory of Microstructure and Property of Advanced Materials, Institution, Beijing University of Technology, Faculty of Materials and Manufacturing, Beijing, 100124, China
- Department: Department of Materials Science and Engineering, Institution: Southern University of Science and Technology, Shenzhen, 518055, China
| | - Xiaozhou Liao
- Department: School of Aerospace, Mechanical and Mechatronic Engineering, Institution, The University of Sydney, J07 The University of Sydney, New South Wales, 2006, Australia
| | - Jun Huang
- Department: School of Chemical and Biomolecular Engineering, Institution: The University of Sydney, J01 The University of Sydney, New South Wales, 2006, Australia
| | - Assaad R Masri
- Department: School of Aerospace, Mechanical and Mechatronic Engineering, Institution, The University of Sydney, J07 The University of Sydney, New South Wales, 2006, Australia
| |
Collapse
|
5
|
Vidović K, Hočevar S, Grgić I, Metarapi D, Dominović I, Mifka B, Gregorič A, Alfoldy B, Ciglenečki I. Do bromine and surface-active substances influence the coastal atmospheric particle growth? Heliyon 2024; 10:e31632. [PMID: 38828296 PMCID: PMC11140702 DOI: 10.1016/j.heliyon.2024.e31632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 05/16/2024] [Accepted: 05/20/2024] [Indexed: 06/05/2024] Open
Abstract
New particle formation (NPF) is considered a major source of aerosol particles and cloud condensation nuclei (CCN); however, our understanding of NPF and the subsequent particle growth mechanisms in coastal areas remains limited. This study provides evidence of frequent NPF events followed by particle growth in the middle Adriatic Sea during the summer months at the coastal station of Rogoznica in Croatia. To our knowledge, this is the first study to report such events in this region. Our research aims to improve the understanding of NPF by investigating particle growth through detailed physicochemical characterization and event classification. We used a combination of online measurements and offline particle collection, followed by a thorough chemical analysis. Our results suggest the role of bromine in the particle growth process and provide evidence for its involvement in combination with organic compounds. In addition, we demonstrated the significant influence of surface-active substances (SAS) on particle growth. NPF and particle growth events have been observed in air masses originating from the Adriatic Sea, which can serve as an important source of volatile organic compounds (VOC). Our study shows an intricate interplay between bromine, organic carbon (OC), and SAS in atmospheric particle growth, contributing to a better understanding of coastal NPF processes. In this context, we also introduced a new approach using the semi-empirical 1st derivative method to determine the growth rate for each time point that is not sensitive to the nonlinear behavior of the particle growth over time. We observed that during NPF and particle growth event days, the OC concentration measured in the ultrafine mode particle fraction was higher compared to non-event days. Moreover, in contrast to non-event days, bromine compounds were detected in the ultrafine mode atmospheric particle fraction on nearly all NPF and particle growth event days. Regarding sulfuric acid, the measured sulfate concentration in the ultrafine mode atmospheric particle fraction on both NPF event and non-event days showed no significant differences. This suggests that sulfuric acid may not be the primary factor influencing the appearance of NPF and the particle growth process in the coastal region of Rogoznica.
Collapse
Affiliation(s)
- Kristijan Vidović
- National Institute of Chemistry, Department of Analytical Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia
- Ruđer Bošković Institute, Division for Marine and Environmental Research, Laboratory for Physical Oceanography Chemistry of Aquatic Systems, Bijenička cesta 54, 10000, Zagreb, Croatia
| | - Samo Hočevar
- National Institute of Chemistry, Department of Analytical Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia
| | - Irena Grgić
- National Institute of Chemistry, Department of Analytical Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia
| | - Dino Metarapi
- National Institute of Chemistry, Department of Analytical Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia
| | - Iva Dominović
- Ruđer Bošković Institute, Division for Marine and Environmental Research, Laboratory for Physical Oceanography Chemistry of Aquatic Systems, Bijenička cesta 54, 10000, Zagreb, Croatia
| | - Boris Mifka
- Faculty of Physics University of Rijeka, Radmile Matejčić 2, 51000, Rijeka, Croatia
| | - Asta Gregorič
- University of Nova Gorica, Center for Atmospheric Research, Vipavska 11c, 5270 Ajdovščina, Slovenia
- Aerosol d.o.o., Kamniška 39A, 1000, Ljubljana, Slovenia
| | | | - Irena Ciglenečki
- Ruđer Bošković Institute, Division for Marine and Environmental Research, Laboratory for Physical Oceanography Chemistry of Aquatic Systems, Bijenička cesta 54, 10000, Zagreb, Croatia
| |
Collapse
|
7
|
Oliveira M, Sousa A, Sá S, Soares S, Pereira AC, Rocha AC, Pais P, Ferreira D, Almeida C, Luís C, Lima C, Almeida F, Gestoso Á, Duarte MC, Barata P, Martins-Mendes D, Baylina P, Pereira CF, Fernandes R. Harvesting the Power of Green Synthesis: Gold Nanoparticles Tailored for Prostate Cancer Therapy. Int J Mol Sci 2024; 25:2277. [PMID: 38396953 PMCID: PMC10889744 DOI: 10.3390/ijms25042277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2024] [Revised: 01/26/2024] [Accepted: 02/09/2024] [Indexed: 02/25/2024] Open
Abstract
Biosynthetic gold nanoparticles (bAuNPs) present a promising avenue for enhancing bio-compatibility and offering an economically and environmentally responsible alternative to traditional production methods, achieved through a reduction in the use of hazardous chemicals. While the potential of bAuNPs as anticancer agents has been explored, there is a limited body of research focusing on the crucial physicochemical conditions influencing bAuNP production. In this study, we aim to identify the optimal growth phase of Pseudomonas aeruginosa cultures that maximizes the redox potential and coordinates the formation of bAuNPs with increased efficiency. The investigation employs 2,6-dichlorophenolindophenol (DCIP) as a redox indicator. Simultaneously, we explore the impact of temperature, pH, and incubation duration on the biosynthesis of bAuNPs, with a specific emphasis on their potential application as antitumor agents. Characterization of the resulting bAuNPs is conducted using ATR-FT-IR, TEM, and UV-Vis spectroscopy. To gain insights into the anticancer potential of bAuNPs, an experimental model is employed, utilizing both non-neoplastic (HPEpiC) and neoplastic (PC3) epithelial cell lines. Notably, P. aeruginosa cultures at 9 h/OD600 = 1, combined with biosynthesis at pH 9.0 for 24 h at 58 °C, produce bAuNPs that exhibit smaller, more spherical, and less aggregated characteristics. Crucially, these nanoparticles demonstrate negligible effects on HPEpiC cells while significantly impacting PC3 cells, resulting in reduced viability, migration, and lower IL-6 levels. This research lays the groundwork for the development of more specialized, economical, and ecologically friendly treatment modalities.
Collapse
Affiliation(s)
- Marco Oliveira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - André Sousa
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
| | - Sara Sá
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
| | - Sílvia Soares
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Ana Cláudia Pereira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Ana Catarina Rocha
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Patrick Pais
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- ECVA-UTAD, Escola de Ciências da Vida e do Ambiente, Universidade de Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal
| | - Diogo Ferreira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
- TBIO, Center for Translational Health and Medical Biotechnology Research, ESS-IPP, Escola S. Saúde, Instituto Politécnico do Porto, 4200-465 Porto, Portugal
| | - Cátia Almeida
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Carla Luís
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Cláudio Lima
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Fábio Almeida
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Álvaro Gestoso
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Miguel-Correa Duarte
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
- CINBIO, University of Vigo, 36310 Vigo, Spain
- Southern Galicia Institute of Health Research (IISGS), Biomedical Research Networking Center for Mental Health (CIBERSAM), 36310 Madrid, Spain
| | - Pedro Barata
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Daniela Martins-Mendes
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Pilar Baylina
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- TBIO, Center for Translational Health and Medical Biotechnology Research, ESS-IPP, Escola S. Saúde, Instituto Politécnico do Porto, 4200-465 Porto, Portugal
| | - Carla F. Pereira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Rúben Fernandes
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| |
Collapse
|
8
|
Benatti Justino A, Prado Bittar V, Luiza Borges A, Sol Peña Carrillo M, Sommerfeld S, Aparecida Cunha Araújo I, Maria da Silva N, Beatriz Fonseca B, Christine Almeida A, Salmen Espindola F. Curcumin-functionalized gold nanoparticles attenuate AAPH-induced acute cardiotoxicity via reduction of lipid peroxidation and modulation of antioxidant parameters in a chicken embryo model. Int J Pharm 2023; 646:123486. [PMID: 37802259 DOI: 10.1016/j.ijpharm.2023.123486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 09/16/2023] [Accepted: 10/03/2023] [Indexed: 10/08/2023]
Abstract
Gold nanoparticles (AuNPs) have gained considerable attention due to their biocompatibility, customizable optical properties and ease of synthesis. In this study, an environmentally friendly method was used for synthesize curcumin-functionalized AuNPs (AuNP-C). AuNP-C exhibited a spherical shape, uniformity, and an average diameter of 6 nm. The in vitro antioxidant activity was analyzed, and cytotoxicity properties of AuNP-C were assessed in fibroblast and macrophage cells. Additionally, the effects of AuNP-C on oxidative stress in chicken embryo liver and hearts were investigated. AuNP-C demonstrated potent free radical scavenging properties without exhibiting cytotoxicity and hepatotoxicity effects. Administration of 300 µg/mL of AuNP-C in chicken embryos, subjected to oxidative damage induced by 2,2'-azobis(2-amidinopropane) dihydrochloride, significantly reduced lipid peroxidation and reactive oxygen species levels in the cardiac tissue. Moreover, the activities of cardiac superoxide dismutase, catalase, and glutathione reductase were restored, accompanied by an increase in overall antioxidant capacity. Furthermore, at higher concentrations, AuNP-C normalized the reduced glutathione content. AuNP-C preserved the normal structure of blood vessels; however, it resulted in an increase in protein carbonylation. This study provides initial evidence for the modulation of antioxidant defense mechanisms by green-synthesized AuNPs and underscores the importance of investigating the in vivo safety of phytoantioxidant-functionalized nanoparticles.
Collapse
Affiliation(s)
- Allisson Benatti Justino
- Biochemistry and Molecular Biology Laboratory, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Brazil; Laboratory of New Nanostructured and Functional Materials, Physics Institute, Federal University of Alagoas, Maceio, Brazil; Postgraduate Program of the Northeast Biotechnology Network (RENORBIO), Federal University of Alagoas, Maceio, Alagoas, Brazil
| | - Vinicius Prado Bittar
- Biochemistry and Molecular Biology Laboratory, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Brazil
| | - Ana Luiza Borges
- Biochemistry and Molecular Biology Laboratory, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Brazil
| | - María Sol Peña Carrillo
- Biochemistry and Molecular Biology Laboratory, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Brazil
| | - Simone Sommerfeld
- School of Veterinary Medicine, Federal University of Uberlandia, Uberlandia, Brazil
| | | | - Neide Maria da Silva
- Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia, Brazil
| | | | - Anielle Christine Almeida
- Laboratory of New Nanostructured and Functional Materials, Physics Institute, Federal University of Alagoas, Maceio, Brazil; Postgraduate Program of the Northeast Biotechnology Network (RENORBIO), Federal University of Alagoas, Maceio, Alagoas, Brazil
| | - Foued Salmen Espindola
- Biochemistry and Molecular Biology Laboratory, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Brazil.
| |
Collapse
|